The Japanese Journal of Pharmacology
Online ISSN : 1347-3506
Print ISSN : 0021-5198
ISSN-L : 0021-5198
Full Papers
Partial Agonistic Effects of Carteolol on Atypical β-Adrenoceptors in the Guinea Pig Gastric Fundus
Takahiro HorinouchiKatsuo Koike
Author information
JOURNAL FREE ACCESS

2000 Volume 84 Issue 3 Pages 287-292

Details
Abstract

The properties of the β1-/β2-adrenoceptor partial agonist carteolol were investigated in atypical β-adrenoceptors on the guinea pig gastric fundus. Carteolol induced concentration-dependent relaxation in this tissue (pD2=5.55, intrinsic activity=0.94). However, a combination of the selective β1-adrenoceptor antagonist atenolol (100 μM) and the selective β2-adrenoceptor antagonist butoxamine (100 μM) produced only small rightward shifts in the concentration-response curves of carteolol in the gastric fundus (pD2=4.91, intrinsic activity=0.94). In the presence of both atenolol (100 μM) and butoxamine (100 μM), the non-selective β1-, β2- and β3-adrenoceptor antagonist (±)-bupranolol (10-100 μM) caused a concentration-dependent right-ward shift of the concentration-response curves for carteolol in the guinea pig gastric fundus. Schild plot analyses of the effects of (±)-bupranolol against carteolol gave the pA2 value of 5.29 and the Schild slope was not significantly different from unity. Furthermore, carteolol (10 μM) weakly but significantly antagonized the relaxant responses to catecholamines ((−)-isoprenaline, (−)-noradrenaline and (−)-adrenaline), a selective β3-adrenoceptor agonist BRL37344 ((R*, R*)-(±)-4-[2-[(2-(3-chlorophenyl)-2-hydroxyethyl)amino]propyl]phenoxyacetic acid sodium salt) and a non-conventional partial β3-adrenoceptor agonist (±)-CGP12177A ([4-[3-[(1, 1-dimethylethyl)amino]-2-hydroxypropoxy]-1, 3-dihydro-2H-benzimidazol-2-one] hydrochloride) in the guinea pig gastric fundus. These results suggest that the partial agonistic effects of carteolol are mediated by atypical β-adrenoceptors in the guinea pig gastric fundus.

Content from these authors
© The Japanese Pharmacological Society 2000
Previous article Next article
feedback
Top